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RNA G-quadruplex (G4) structures are thought to affect biological processes, 
including translation and pre-mRNA splicing, but it is not possible at present to 
demonstrate that they form naturally at specific sequences within long 
functional RNA molecules. We have developed a novel strategy, footprinting of 
long 7-deazaguanine substituted RNAs (FOLDeR), that allows the formation of 
G4s to be confirmed in long RNAs and in functional conditions.  
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G-rich sequences in DNA or RNA have the potential to form four-stranded structures 
known as G-quadruplexes (G4)1. DNA G4 formation has been demonstrated in vivo2 
and implicated in a very wide range of gene expression processes, notably telomere 
maintenance, transcription and genome instability3. RNA G4s exist in vivo4 and have 
been implicated in various post-transcriptional processes5-10. They would be expected 
to form more readily in RNA than in DNA, but it is still difficult to predict whether 
they do form in any given RNA sequence.  
 
G4s have been suggested previously to be of functional significance in pre-mRNA 
splicing. Most of these studies used similar approaches, using bioinformatic tools to 
identify well-characterized G4-forming sequences and biophysical methods to show 
that the predicted G4 can form in isolated short sections of RNA11-13. However, such 
sequences are naturally part of longer pre-mRNAs in which the propensity of a 
sequence to form a G4 is determined by competition with secondary structures and 
protein binding. Other methods for identifying G4s include the use of ligands or 
antibodies that bind selectively to G4s4,13,14, but a general hazard is that the binding 
reagent affects the equilibrium between different structures and thus might induce the 
formation of otherwise unstable non-functional G4s. Mutagenesis is often used for 
confirmation of G4 formation in vivo12,15, but mutants need to be designed so as not 
to affect the binding of regulatory proteins or perturb likely secondary structures.  
 
We describe here a method in which we probed the secondary structure of an entire 
functional unit of pre-mRNA, comparing native RNA with 7-deazaguanine (7-deaza-
G) substituted RNA, which can form the same secondary structures but not G4s16. 
Differences, highlighted regions in which G4 might form. These differences were 
 4 
confirmed in functional splicing conditions by ribonuclease H digestion in nuclear 
extracts. This method allowed the identification of functionally relevant G4s.  
 
The splicing reaction we have studied is that of the human B-cell lymphoma-extra 
large (Bcl-x) pre-mRNA, which KDVWZRDOWHUQDWLYH¶VSOLFHVLWHV¶66in its exon 2. 
The major isoform, Bcl-xL (XL), is an anti-apoptotic factor, while the alternative 
isoform, Bcl-xS (XS), is pro-apoptotic
17. There are a number of guanine-rich (G-rich) 
sequences in the regions around the Bcl-x alternative splice sites that could form G4s.  
 
We designed a functional splicing transcript, Bcl-x-681, by preserving the sequence 
between the alternative XS and XL 5¶66 shortening the intron and the exon 3 and 
DGGLQJ DQ DGGLWLRQDO ¶66 DW WKH ¶HQG RI WKH FRQVWUXFW (Fig. 1a). Splicing of this 
transcript substantially favored the Bcl-xL isoform, recapitulating the preference for 
Bcl-xL observed in HeLa cells
18 (Fig. 1b, Supplementary Fig. 1).  
 
The presence of G4s in this functional RNA was assessed by an electrophoretic 
mobility shift assay (EMSA) using a previously described G4-specific antibody, 
BG42,4, that induced a shift in the migration of the Bcl-x-681 RNA (Fig. 1c, left). 
This transcript contains 6 G-rich sequences predicted to potentially form a G419, one 
upstream of the XS splice site (Q1), three between the XS and the XL splice sites (Q2, 
Q3 and Q4), and one downstream RIWKH¶VSOLFHVLWH¶66(Q6). All of these short 
sequences displayed a circular dichroism spectrum that is typical for parallel G4s, 
with a positive signal at 265 nm and a negative signal at 240 nm (Supplementary Fig. 
2).  The stability of these G4s ranged from 37°C (Q4) to >70°C (Q2). However, these 
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experiments did not provide information on whether these sequences do form in the 
face of competing secondary structures in functional Bcl-x pre-mRNA. 
 
Therefore, our strategy for identifying the location of G4 elements in this RNA was 
to (i) map structured regions using ribonucleases (RNases), and then (ii) repeat the 
assay with 7-deaza-G-RNA, in which G4s would not form16.  For (i), we performed 
RNA footprinting using RNases T1, T2 and V1, providing structural restraints at 
nucleotide resolution (Supplementary Figs. 3 and 4). In total, we defined 163 and 91 
nucleotides as single-stranded and double-stranded, respectively (Supplementary Fig. 
4, Supplementary Dataset 1). We used these restraints with a secondary structure 
prediction software (Mfold20) to derive the best fit model (Supplementary Fig. 6). 
This model predicted that the Bcl-x-681 RNA is highly structured and suggested the 
presence of four structurally independent domains, denoted as XS, XL, intron and 3¶VV 
domains according to the splicing elements they contained (Supplementary Fig. 6). 
We transcribed each structural domain separately and RNA footprints of each domain 
showed a very similar footprinting pattern to that of the full-length RNA 
(Supplementary Fig. 7), supporting the structural model. 
 
To identify potential G4s within this structure, we replaced all guanines by 7-deaza-G 
during in vitro transcription. The absence of the N7 in the 7-deaza-G was shown 
previously to abolish the possibility of Hoogsteen base pairing and thus of G4 
formation, whilst still permitting Watson-Crick base-pairing and the formation of 
stem-loops16. We confirmed the absence of G4s in the 7-deaza-G Bcl-x-681 RNA by 
EMSA. As expected, BG42,4 did not induce a shift in the migration of the 7-deaza-G 
RNA (Fig. 1c, right).  
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We performed RNA footprinting on the 7-deaza-G RNA (Supplementary Fig. 4) and 
a comparison between the RNA footprinting of the 7-deaza-G-substituted  transcripts 
and the native transcript was assessed by calculating an index factor corresponding to 
(V1 7-deaza-G / V1 native) / (T2 7-deaza-G / T2 native) (Supplementary Dataset 2, 
left). The majority of the 40 nucleotides having a index value below 0.3 or above 3, 
indicating a three-fold difference in structural probing between the native and the 7-
deaza-G RNA) were located in the XS and the XL domains, and many of these 
nucleotides coincided with two of the possible G4 regions (Q2, and Q5) (Fig. 1d). 
We repeated the same experiment in the presence of a G4 binding compound and 
observed a similar footprinting pattern (Supplementary dataset 2, right table; 
Supplementary Fig.8). We therefore concluded that the Bcl-x-681 transcript contains 
G4s located near the XS and XL splice sites. Previous reports identified G4s by 
comparing structural probing of RNAs in the presence of either potassium (K+) or 
Lithium (Li+) ions8, although on much shorter sequences than Bcl-x-681. For 
comparison, we performed an RNA footprinting experiment of Bcl-x-681 in the 
presence of Li+ or K+ ions (Supplementary Dataset 3) and calculated an index as (V1 
K+ / V1 Li+) / (T2 K+ / T2 Li+). Only 5 nucleotides displayed an index below 0.3 or 
above 3. In order to compare this strategy with our strategy using deaza-G-substituted 
RNA, we therefore considered the 40 nucleotides that displayed an index below 0.5 
or above 2 (Supplementary Fig. 89). The majorities of these nucleotides were located 
in the XS and XL domains and coincided mainly with Q2. These results validated the 
use of our 7-deaza-GTP substitution strategy for mapping G4s in long RNAs and, 
importantly, showed that the use of 7-deaza-G substitution is more sensitive than the 
comparison of structural probing in K+ and Li+ containing buffers. 
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A major benefit of using 7-deaza-G RNA in structural probing is that, in contrast to 
the comparison between Li+ and K+ buffers, it can be done in functional conditions, 
such as in nuclear extracts. Therefore, we tested the accessibility of native and 7-
deaza-G modified Bcl-x-681 RNAs using RNAse H cleavage directed by 10-mer 
DNA oligonucleotides in functional splicing conditions in nuclear extracts 
(Supplementary Fig. 109). We focused our analysis on the XS, and XL domains. We 
assigned protected or accessible regions on the basis of either  40% or ! 60% 
cleavage, respectively (Supplementary Fig. 109). The RNAse H cleavage patterns of 
native RNA in nuclear extract were in good agreement with the structure predicted in 
solution (Fig. 2a). Putative stems were protected in both the XS and XL domains, 
while several of the predicted loops were accessible. Comparison of the RNAse H 
patterns of the native and the 7-deaza-G RNA (Fig. 2b) showed major differences 
mainly near the putative G4s, especially Q2 and Q5, consistent with the footprinting 
results. These data demonstrated that the use of 7-deaza-G RNA can identify G4s in 
functional splicing conditions.  
 
In conclusion, we have described FOLDeR, a new method that allowed us to 
demonstrate the presence of G4s within long RNAs by using 7-deaza-G RNA 
modifications in combination with secondary structure probing (Fig. 1). By coupling 
footprinting with ribonuclease H cleavage assays on the two different types of 
transcript, it was also possible to validate the findings in functional conditions, such 
as nuclear extracts (Fig. 2). Although we demonstrated the power of this method 
using nuclease digestions, its validity relies on the modification of the RNA and not 
on the structural probing method. Therefore, the use of 7-deaza-G RNAs to probe 
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G4s could also be done in combination with other structural probing methods such as 
sHOHFWLYHƍ-hydroxyl acylation analyzed by primer extension (SHAPE) chemistry21 or 
dimethyl sulphate (DMS) footprinting22. It is now becoming clear that RNA G4s 
have a higher propensity to form than their DNA counterparts. Recently, structural 
data revealed the presence of RNA G4s that could not be predicted by bioinformatics 
tools13,23,24,25. The development of an experimental method for identifying and 
locating G4s is therefore a major step forward. The existence of G4s in a functional 
RNA can be tested using the BG4 antibody4 and their location established using 7-
deaza-G-RNA as described here. 
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Figure Legends: 
 
Figure 1: The functional Bcl-x-681 RNA contains G4s in vitro 
(a) Schematic representation of native Bcl-x (top) and Bcl-x-681 transcript (bottom) 
used in this study. The size of introns and exons are indicated in nucleotides below 
the diagrams. XL and XS ¶VSOLFHVLWHVDUHLQGLFDWHGDERYHWKHGLDJUDPVb) In vitro 
splicing assay of Bcl-x-681. Bands corresponding to the unspliced transcript, the XL 
and the XS products are labelled. The full-length gel is displayed in Supplementary 
Fig. 1 (c) Electrophoretic-mobility shift assay of native (left) and 7-deaza-G 
substituted (right) Bcl-x-681 in the absence or presence of increasing amount of BG4 
antibody (0, 150 pM, 1.5 nM, 15 nM, Q0DQGȝ0). The full-length gel is 
displayed in Supplementary Fig. 10. (d) Mapping of RNA footprinting of Bcl-x-681. 
Nucleotides having a significantly different footprinting pattern upon 7-deaza-GTP 
substitution are circled and are located mainly to the XS and XL domains. Putative 
G4s are labelled Q1 to Q6. 
 
Figure 2: The Bcl-x-681 RNA contains G4s in functional conditions 
 (a) Schematic drawing of the RNAse H cleavage of native Bcl-x-681 on the 
secondary structure model of Bcl-x-681. Accessible regions (average >60% cleavage) 
are in black, and protected regions (average <40% cleavage) are in grey. RNAse 
cleavage experiments were done in triplicate and are presented in supplementary 
Figure 9A. (b) Percentage of change of RNAse H cleavages in 7-deaza-G versus 
native RNA. Positive changes indicate increase in accessibility while negative 
changes indicate increase in protection. Data represent the difference between the 
average of three RNAse H cleavage experiments on native RNA (supplementary 
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Figure 9A) and the average of three RNAse H cleavage  experiments on 7-deaza-G 
RNA (supplementary Figure 9B). 
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Online Methods: 
 
In Vitro Transcription of RNA  
A transcription reaction containing 40 mM Tris (pH 7.5), 20 mM MgCl2, 10 mM 
NaCl, 2 mM spermidine HCl, 10 mM DTT, 4 mM NTPs, 1 Pg DNA template (PCR 
product), 5% RNaseOut (Invitrogen), and 5% T7 polymerase (1:20 dilution) was 
incubated at 37 qC for 4 h. DNA fragments were removed using an S-300 column 
(GE Healthcare). The product was extracted by phenol-chloroform and precipitated 
by ethanol. The pellet was dissolved in the desired amount of TE buffer and stored at 
±20 qC.  For radiolabelled RNA, A transcription reaction containing 40 mM Tris (pH 
7.5), 6 mM MgCl2, 10 mM NaCl, 2 mM spermidine HCl, 0.5 mM ATP, 0.5 mM 
CTP, 0.5 mM UTP, 0.05 mM GTP, 50 ng DNA template (PCR product), 4% 
RNaseOut, 10% T7 (1:20 dilution), 1 mM Ribo m7G Cap analogue (Promega) and 
0.33 PM [D-32P] GTP (10 mCi/ml, 3000 Ci/mmol) (Pelkin Elmer) was incubated at 
37 qC for 1.5 h. Samples were then purified via a denaturing gel. 
 
In vitro transcription of 7-deaza RNA 
A transcription reaction containing 40 mM Tris (pH 7.5), 20 mM MgCl2, 10 mM 
NaCl, 2 mM spermidine HCl, 10 mM DTT, 4 mM NTPs (c7GTP instead of GTP), 1 
Pg DNA template (PCR product), 5% RNaseOut, 2 mM Ribo m7G Cap analogue 
(Promega) and 5% T7 (1:20 dilution) was incubated at 37 qC for 4 h. DNA fragments 
were removed using an S-300 column (GE Healthcare). The product was extracted by 
phenol-chloroform and precipitated by ethanol. The pellet was dissolved in the 
desired amount of TE buffer and stored at ±20 qC. For radiolabelled deaza RNA, A 
transcription reaction containing 40 mM Tris (pH 7.5), 6 mM MgCl2, 10 mM NaCl, 
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2 mM spermidine HCl, 0.5 mM ATP, 0.5 mM CTP, 0.5 mM UTP, 0.05 mM GTP, 50 
ng DNA template (PCR product), 4% RNaseOut, 10% T7 (1:20 dilution), 1 mM Ribo 
m7G Cap analogue (Promega) and 0.33 PM [D-32P] GTP (10 mCi/ml, 3000 
Ci/mmol) (Pelkin Elmer) was incubated at 37 qC for 1.5 h. Samples were then 
purified via a denaturing gel. 
 
In Vitro Splicing of RNA  
Samples containing 1.53 mM ATP, 20 mM CrPi, 3.2 mM MgCl2, 20 mM Hepes (pH 
7.5), 50 mM KGlu, 0.125% NP-40, 50% nuclear extract (Cilbiotech) and 10±20 cps 
RIUDGLRODEHOOHG51$WUDQVFULSWZHUHVHWXSLQȝOUHDFWLRQVRQLFHWKHQLQFXEDWHG
at 30 qC for 2 h in a pre-KHDWHG ZDWHUEDWK $OLTXRWV RI  ȝO ZHUH WDNHQ LQWR D
microtitre plate on dry ice at timepoints 0, 30, 60 and 120 min.  Samples were then 
treated by addition of 50 µl of 0.4 mg/ml proteinase K and incubation for 10 mins at 
37 °C. Samples were  precipitated WZLFHZLWKHWKDQRODQGGLVVROYHGLQȝO
formamide dyes.  To prepare for loading on an 8% denaturing polyacrylamide gel, 
samples were placed in boiling water for 30 sec and run until bromophenol blue has 
just run out of the gel. Gels were then fixed, dried and exposed to a phosphorimaging 
screen overnight. Quantification of pre-mRNA and both mRNA products was done 
using OptiQuant software, and intensities were normalised to account for the number 
of guanines in each RNA species.   
 
RNase probing  
Samples containing 400 ng RNA (either native or 7-deaza-substituted), 0.5 mg/ml 
yeast tRNA, and either 150 mM KCl, 1.5 mM MgCl2 and 20 mM Hepes pH 7.6 (K
+ 
containing buffer) or 150 mM KCl, 1.5 mM MgCl2 and 20 mM Hepes pH 7.6 (Li+ 
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containing buffer) in a total volume of 9 µl, were heated at 65 qC in a water bath for 
10 min then slow cooled to 37 qC. 1 µl of either Tris buffer (0.5 mM Tris pH 7.6, 1 
M KCl or 1M LiCl, and 25 mM MgCl2), RNase T1 (Roche Diagnostics), RNase T2 
(Ambion) or RNase V1 (Mobitech) was added.  Reactions were incubated at ambient 
temperature for 6 min then stopped with 101.8 µl of stop buffer (3.9 mM EDTA and 
0.2 µg yeast tRNA) and 101.8 µl phenol-chloroform then spun at 13,500 rpm for 10 
min. The top layer was removed and added to 700 µl ethanol (96%), 12 ng glycogen 
and 22 mM NaAc (pH 3.0). Samples were then ethanol-precipitated and dissolved in 
4 µl potassium borate or sterile water.    
 
Reverse transcription of probed RNA 
A hybridization mix was made containing 0.25 µl hybridization buffer (reverse 
transcription buffer without MgCl2), 1 µl of 100 cps/µL radiolabelled primer and 0.25 
µl water. 1 µl of probed RNA was incubated with 1.5 µl of hybridization mix at 65 
qC for 10 min then cooled on ice.  2.5 µl of extension mix (0.1 µl 5 mM dNTPs, 0.25 
µl reverse transcriptase buffer, 0.25 µl 1/10 diluted AMV reverse transcriptase (MP 
Biomedical) and 1.9 µl water) was added to each probed RNA mix and incubated at 
42 qC for 30 min.  3 µl formamide dye was added and the sample was heated to 96 
qC for 2 min, and then put on ice for 2 min.  2 µl was loaded onto 7% DNA 
sequencing gel and run for 2 h at 100 W. Gels were dried and exposed to a 
phosphorimaging screen overnight and quantified using SAFA.   
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RNase H assays 
RNase H cleavage was done in triplicate in splicing conditions by adding DNA 
oligonucleotide at 10 µM after incubation for 30 min and continuing incubation for 5 
min. Reactions were processed as for splicing reactions.  
 
Electromobility Shift assays (EMSA) 
The BG4 antibody was purchased from Absolute Antibody (Ab00174-1.1). 
Radiolabelled RNA at 10 count per seconds was incubated with various 
FRQFHQWUDWLRQVS0Q0Q0Q0DQGȝ0RI%*DQWLERG\LQ
a microtitre plate.  3 µl of native gel dye was added, and 4 µl was run on a small 5% 
native poyacylamide gel at 4qC.  The gel was run at 5 W for 1 h. Gels were dried and 
exposed to a phosphorimager screen overnight.   
 
Circular Dichroism 
RNA sequences corresponding to Q1, Q2, Q3, Q4, Q5, and Q6 were purchased from 
Dharmacon, GE Healthcare, deprotected according to the manufacturer instructions, 
lyophilised, and resuspended in 20mM KH2PO4, pH7, 100mM KCl at a final 
concentration of 20PM. Circular dichroism spectra were acquired on a Chirascan 
spectrometer at 20°C and data were collected between 350 and 220nm in triplicate 
and averaged. Buffer baseline was substracted for each spectrum. CD Melting curves 
were obtained by measuring the CD signal at 265nm from 20 to 80°C at 1°C heating 
rate. 
